TY - JOUR
T1 - A personalized eHealth intervention for lifestyle changes in patients with cardiovascular disease:
T2 - Randomized controlled trial
AU - Broers, E.R.
AU - Kop, W.J.
AU - Denollet, J.
AU - Widdershoven, J.W.G.M.
AU - Wetzels, M.
AU - Ayoola, I.
AU - Piera-Jimenez, J.
AU - Habibovic, M.
N1 - This study was funded by the European Commission’s Horizon 2020 program (grant number: 463735). For this project, the Do CHANGE team received funding for research and innovation from the European Union. One startup (Onmi) and 2 small- and medium-sized enterprises (DSD, Docobo Ltd) are supported financially to develop their products.
PY - 2020
Y1 - 2020
N2 - Background: Behavior change methods involving new ambulatory technologies may improve lifestyle and cardiovascular disease outcomes. Objective: This study aimed to provide proof-of-concept analyses of an intervention aiming to increase (1) behavioral flexibility, (2) lifestyle change, and (3) quality of life. The feasibility and patient acceptance of the intervention were also evaluated. Methods: Patients with cardiovascular disease (N=149; mean age 63.57, SD 8.30 years; 50/149, 33.5% women) were recruited in the Do Cardiac Health Advanced New Generation Ecosystem (Do CHANGE) trial and randomized to the Do CHANGE intervention or care as usual (CAU). The intervention involved a 3-month behavioral program in combination with ecological momentary assessment and intervention technologies. Results: The intervention was perceived to be feasible and useful. A significant increase in lifestyle scores over time was found for both groups (F 2,146.6=9.99; P<.001), which was similar for CAU and the intervention group (F 1,149.9=0.09; P=.77). Quality of life improved more in the intervention group (mean 1.11, SD 0.11) than CAU (mean −1.47, SD 0.11) immediately following the intervention (3 months), but this benefit was not sustained at the 6-month follow-up (interaction: P=.02). No significant treatment effects were observed for behavioral flexibility (F 1,149.0=0.48; P=.07). Conclusions: The Do CHANGE 1 intervention was perceived as useful and easy to use. However, no long-term treatment effects were found on the outcome measures. More research is warranted to examine which components of behavioral interventions are effective in producing long-term behavior change.
AB - Background: Behavior change methods involving new ambulatory technologies may improve lifestyle and cardiovascular disease outcomes. Objective: This study aimed to provide proof-of-concept analyses of an intervention aiming to increase (1) behavioral flexibility, (2) lifestyle change, and (3) quality of life. The feasibility and patient acceptance of the intervention were also evaluated. Methods: Patients with cardiovascular disease (N=149; mean age 63.57, SD 8.30 years; 50/149, 33.5% women) were recruited in the Do Cardiac Health Advanced New Generation Ecosystem (Do CHANGE) trial and randomized to the Do CHANGE intervention or care as usual (CAU). The intervention involved a 3-month behavioral program in combination with ecological momentary assessment and intervention technologies. Results: The intervention was perceived to be feasible and useful. A significant increase in lifestyle scores over time was found for both groups (F 2,146.6=9.99; P<.001), which was similar for CAU and the intervention group (F 1,149.9=0.09; P=.77). Quality of life improved more in the intervention group (mean 1.11, SD 0.11) than CAU (mean −1.47, SD 0.11) immediately following the intervention (3 months), but this benefit was not sustained at the 6-month follow-up (interaction: P=.02). No significant treatment effects were observed for behavioral flexibility (F 1,149.0=0.48; P=.07). Conclusions: The Do CHANGE 1 intervention was perceived as useful and easy to use. However, no long-term treatment effects were found on the outcome measures. More research is warranted to examine which components of behavioral interventions are effective in producing long-term behavior change.
KW - Cardiovascular diseases
KW - EHealth
KW - Habits
KW - Lifestyle
KW - MHealth
UR - http://www.scopus.com/inward/record.url?scp=85085538206&partnerID=8YFLogxK
UR - https://clinicaltrials.gov/ct2/show/NCT02946281
U2 - 10.2196/14570
DO - 10.2196/14570
M3 - Article
SN - 1438-8871
VL - 22
JO - Journal of Medical Internet Research (JMIR)
JF - Journal of Medical Internet Research (JMIR)
IS - 5
M1 - e14570
ER -